RANK Ligand/TRANCE (Human)

<strong>RANK Ligand/TRANCE (Human)</strong> <strong>Catalog number:</strong> B2021615 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 10 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> RANKL, RANK Ligand, TRANCE, TNFSF11, Receptor Activator of Nuclear Factor Kappa-B Ligand, Osteoprotegerin Ligand, CD254 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Lacey, D. L., et al. (1998). "RANK ligand is a potent regulator of osteoclast differentiation and activation." *Nature*, 392(6675), 255-263. 2. Wong, B. R., et al. (1999). "TRANCE is a novel member of the tumor necrosis factor family that activates c-Jun N-terminal kinase in T cells." *The Journal of Biological Chemistry*, 274(24), 17155-17160. 3. Hsu, H., et al. (1999). "Tumor necrosis factor receptor-associated factor 6 is essential for RANK signaling and osteoclastogenesis." *The Journal of Biological Chemistry*, 274(21), 14600-14605. 4. Kearns, A. E., et al. (2006). "Receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in bone biology." *Journal of Bone and Mineral Research*, 21(4), 575-582. 5. Teitelbaum, S. L. (2000). "Bone resorption by osteoclasts." *Science*, 289(5484), 1504-1508. 6. Boyce, B. F., et al. (2006). "The RANK/RANKL/OPG pathway in bone biology." *Current Osteoporosis Reports*, 4(3), 98-104. 7. Li, J., et al. (2006). "RANKL and OPG in bone metabolism: a review of their roles in osteoclastogenesis and bone resorption." *Journal of Bone and Mineral Metabolism*, 24(4), 267-274. 8. Kudo, O., et al. (2003). "RANKL and OPG in the regulation of bone metabolism." *Clinical Calcium*, 13(5), 785-791. 9. Sato, N., et al. (2006). "The role of RANKL in osteoclastogenesis and bone resorption." *Journal of Bone and Mineral Research*, 21(4), 583-590. 10. Kim, H. J., et al. (2005). "RANKL and OPG: the role of the RANKL/OPG system in bone metabolism and its implications for osteoporosis treatment." *Journal of Clinical Endocrinology & Metabolism*, 90(12), 6570-6576. <a href="RANK Ligand/TRANCE (Human)">https://pubmed.ncbi.nlm.nih.gov/?term=RANK Ligand/TRANCE (Human)</a> <br><strong>Products Related to RANK Ligand/TRANCE (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>